Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Allograft T Cell Content Influences Early Engraftment after Reduced-Intensity Stem Cell Transplantation (RIST).

Robert M. Dean, MD, Daniel H. Fowler, MD, Nancy M. Hardy, MD, Jeanne Odom, RN, Kathleen Castro, MSN, Michael Krumlauf, RN, Frances T. Hakim, PhD, Claude Sportes, MD, Ronald E. Gress, MD, Michael R. Bishop

Blood (2005) 106 (11): 3662.

https://doi.org/10.1182/blood.V106.11.3662.3662

Published: 2005

Journal Articles

Engraftment Syndrome after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Graft-Versus-Host Disease Prophylaxis and T Cell Dose.

Robert M. Dean, MD, Kyle M. Donley, BA, Juan Gea-Banacloche, MD, Seth M. Steinberg, PhD, Jeanne Odom, RN, Michael Krumlauf, RN, Kathleen Castro, RN, Tracey Chinn, RN, Daniel H. Fowler, MD, Ronald E. Gress, MD, Michael R. Bishop, MD

Blood (2004) 104 (11): 5052.

https://doi.org/10.1182/blood.V104.11.5052.5052

Published: 2004

Journal Articles

Comparison of Empiric Versus Prophylactic Administration of Ceftazidime during Neutropenia Associated with Reduced-Intensity Allogeneic Stem Cell Transplantation (RIST).

Kyle M. Donley, Juan C. Gea-Banacloche, MD, Robert M. Dean, MD, Seth M. Steinberg, PhD, Richard W. Childs, MD, Jeanne Odom, RN, Kathleen Castro, RN, Tracey Chinn, RN, Daniel H. Fowler, MD, Michael R. Bishop, MD

Blood (2004) 104 (11): 5100.

https://doi.org/10.1182/blood.V104.11.5100.5100

Published: 2004

Journal Articles

Immunoablative Chemotherapy before Reduced-Intensity Allogeneic Stem Cell Transplantation: A Strategy to Provide Disease Control and to Enhance Early Graft-Versus-Lymphoma Effects.

Robert M. Dean, MD, Daniel H. Fowler, MD, Frances T. Hakim, PhD, Jeanne Odom, RN, Kathleen Castro, RN, Tracey Chinn, RN, Wyndham H. Wilson, MD, PhD, Ronald E. Gress, MD, Michael R. Bishop, MD

Blood (2004) 104 (11): 1829.

https://doi.org/10.1182/blood.V104.11.1829.1829

Published: 2004

Journal Articles

Immunotherapy and Chemotherapy Can Result in Long-Term Survival for Patients with Recurrent or Progressive Non-Hodgkin’s Lymphoma after Reduced-Intensity Allogeneic Stem Cell Transplantation.

Michael R. Bishop, MD, Robert M. Dean, MD, Wyndham H. Wilson, MD, PhD, Jeanne Odom, RN, Seth Steinberg, PhD, Michael Krumlauf, RN, Claude Kasten-Sportes, MD, Steven Z. Pavletic, MD, Kathleen Castro, RN, Tracey Chinn, RN, Ronald Gress, MD, Daniel H. Fowler, MD

Blood (2004) 104 (11): 1643.

https://doi.org/10.1182/blood.V104.11.1643.1643

Published: 2004

Journal Articles

Severe chronic graft-versus-host disease is characterized by a preponderance of CD4 + effector memory cells relative to central memory cells

Kouhei Yamashita, Uimook Choi, Patricia C. Woltz, Susan F. Foster, Michael C. Sneller, Francis T. Hakim, Daniel H. Fowler, Michael R. Bishop, Steven Z. Pavletic, Marisa Tamari, Kathleen Castro, A. John Barrett, Richard W. Childs, Gabor G. Illei, Susan F. Leitman, Harry L. Malech, Mitchell E. Horwitz

Blood (2004) 103 (10): 3986–3988.

https://doi.org/10.1182/blood-2003-09-3286

Published: 2004

NARROW

Allograft T Cell Content Influences Early Engraftment after Reduced-Intensity Stem Cell Transplantation (RIST).

Engraftment Syndrome after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Graft-Versus-Host Disease Prophylaxis and T Cell Dose.

Comparison of Empiric Versus Prophylactic Administration of Ceftazidime during Neutropenia Associated with Reduced-Intensity Allogeneic Stem Cell Transplantation (RIST).

Immunoablative Chemotherapy before Reduced-Intensity Allogeneic Stem Cell Transplantation: A Strategy to Provide Disease Control and to Enhance Early Graft-Versus-Lymphoma Effects.

Immunotherapy and Chemotherapy Can Result in Long-Term Survival for Patients with Recurrent or Progressive Non-Hodgkin’s Lymphoma after Reduced-Intensity Allogeneic Stem Cell Transplantation.

Severe chronic graft-versus-host disease is characterized by a preponderance of CD4 + effector memory cells relative to central memory cells

Email alerts

ASH Publications

American Society of Hematology

Allograft T Cell Content Influences Early Engraftment after Reduced-Intensity Stem Cell Transplantation (RIST).

Engraftment Syndrome after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Graft-Versus-Host Disease Prophylaxis and T Cell Dose.

Comparison of Empiric Versus Prophylactic Administration of Ceftazidime during Neutropenia Associated with Reduced-Intensity Allogeneic Stem Cell Transplantation (RIST).

Immunoablative Chemotherapy before Reduced-Intensity Allogeneic Stem Cell Transplantation: A Strategy to Provide Disease Control and to Enhance Early Graft-Versus-Lymphoma Effects.

Immunotherapy and Chemotherapy Can Result in Long-Term Survival for Patients with Recurrent or Progressive Non-Hodgkin’s Lymphoma after Reduced-Intensity Allogeneic Stem Cell Transplantation.

Severe chronic graft-versus-host disease is characterized by a preponderance of CD4 + effector memory cells relative to central memory cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only